Last edition
News about "Sanofi & GSK ink collaboration to develop unpreced"
Sanofi & GSK ink collaboration to develop unprecedented vaccine for COVID-19
Sanofi and GSK announced that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic
Sanofi & GSK Ink Collaboration To Develop Unpreced | 16/04/2020 | By Darshana | 317
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members